Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bone Marrow Transplant (BMT)”

141 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 141 results

Large-scale testing (Phase 3)Study completedNCT01015183
What this trial is testing

Prevention Chemotherapy Induced Mucositis by Zinc Sulfate

Who this might be right for
MucositisBone Marrow Transplantation
Tehran University of Medical Sciences 60
Testing effectiveness (Phase 2)Study completedNCT00534469
What this trial is testing

Auto BMT for Non-M3 AML in 1st Remission in Pts </=60y of Age Using Busulfan/FTBI & VP16 as a Prep R

Who this might be right for
Leukemia
City of Hope Medical Center 60
Not applicableEnded earlyNCT01685411
What this trial is testing

Busulfan and Cyclophosphamide Followed By ALLO BMT

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaMyelodysplastic Syndrome
Masonic Cancer Center, University of Minnesota 5
Not applicableStudy completedNCT00584428
What this trial is testing

High Dose Chemo With Autologous BMT for Treatment of Metastatic Breast Cancer

Who this might be right for
Breast Neoplasms
University of Oklahoma 61
Testing effectiveness (Phase 2)Ended earlyNCT01282216
What this trial is testing

Patient-donor Vaccination in the Context of Allogeneic Bone Marrow Transplant With Post-transplant Cyclophosphamide

Who this might be right for
Transplant-Related Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 120
Testing effectiveness (Phase 2)Study completedNCT00849147
What this trial is testing

Bone Marrow Transplant From Partially Matched Donors and Nonmyeloablative Conditioning for Blood Cancers (BMT CTN 0603)

Who this might be right for
Precursor B-Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myeloid, AcuteBurkitt Lymphoma+3 more
Medical College of Wisconsin 55
Testing effectiveness (Phase 2)Looking for participantsNCT01804634
What this trial is testing

Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Who this might be right for
Refractory and/or Relapsed Metastatic Solid Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 60
Not applicableLooking for participantsNCT07145411
What this trial is testing

HPC Offered for PRESERVE Expansion

Who this might be right for
Bone Marrow Transplant (BMT)
Ossium Health, Inc. 10
Early research (Phase 1)Ended earlyNCT00058773
What this trial is testing

Giving Gene Marked EBV Specific T-Cells to Patients Receiving a BMT for Relapsed EBV-Positive Hodgkin Disease

Who this might be right for
Hodgkin DiseaseNon-Hodgkins Lymphoma
Baylor College of Medicine 5
Large-scale testing (Phase 3)Study completedNCT01015261
What this trial is testing

Allogenic Bone Marrow Transplantation (BMT) Compare With Cytoreduction and Chemotherapy in Acute Lymphoblastic Leukemia (ALL) Patients

Who this might be right for
Acute Lymphoblastic Leukemia
Tehran University of Medical Sciences 30
Early research (Phase 1)Ended earlyNCT02370888
What this trial is testing

Lenalidomide After Allo-Hematopoietic Cell Transplant (HCT) in Acute Myelogenous Leukemia (AML) and Myelodysplastic Syndromes (MDS) Subjects With Minimal Residual Disease

Who this might be right for
Leukemia, MyeloidMyelodysplastic Syndromes
University of Florida 11
Testing effectiveness (Phase 2)Looking for participantsNCT03500731
What this trial is testing

Lung and Bone Marrow Transplantation for Lung and Bone Marrow Failure

Who this might be right for
Idiopathic Pulmonary FibrosisEmphysema or COPD
Paul Szabolcs 8
Early research (Phase 1)Study completedNCT02660281
What this trial is testing

URMC Related Haplo-identical Donor BMT

Who this might be right for
Hematological DiseaseImmune DeficienciesSolid Tumors+3 more
University of Rochester 74
Testing effectiveness (Phase 2)Looking for participantsNCT03653338
What this trial is testing

T-Cell Depleted Alternative Donor Bone Marrow Transplant for Sickle Cell Disease (SCD) and Other Anemias

Who this might be right for
Sickle Cell AnemiaBeta-thalassemia MajorDiamond-blackfan Anemia
Paul Szabolcs 5
Early research (Phase 1)Ended earlyNCT03198234
What this trial is testing

Use of T-allo10 in Hematopoietic Stem Cell Transplantation (HSCT) for Blood Disorders

Who this might be right for
AML - Acute Myeloid LeukemiaMDS (Myelodysplastic Syndrome)Mixed Phenotype Acute Leukemia+3 more
Roncarolo, Maria Grazia, MD 5
Testing effectiveness (Phase 2)Looking for participantsNCT03128996
What this trial is testing

Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders

Who this might be right for
Severe Sickle Cell DiseaseBone Marrow Failure SyndromesMetabolic Disorders+3 more
Washington University School of Medicine 29
Testing effectiveness (Phase 2)Ended earlyNCT00002778
What this trial is testing

Sargramostim Following Allogeneic Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 40
Not applicableUnknownNCT02082353
What this trial is testing

Patients Treated for Chronic Granulomatous Disease (CGD) Since 1995

Who this might be right for
Granulomatous Disease, Chronic
National Institute of Allergy and Infectious Diseases (NIAID) 1,480
Testing effectiveness (Phase 2)Study completedNCT00745420
What this trial is testing

Evaluating the Safety and Effectiveness of Bone Marrow Transplants in Children With Sickle Cell Disease (BMT CTN 0601)

Who this might be right for
Sickle Cell Disease
Medical College of Wisconsin 30
Testing effectiveness (Phase 2)Ended earlyNCT02963064
What this trial is testing

JSP191 Antibody Targeting Conditioning in SCID Patients

Who this might be right for
SCID
Jasper Therapeutics, Inc. 23
Load More Results